Post-tuberculosis lung disease

Area of Science:

• Pulmonology
• Infectious Diseases
• Public Health

Background:

• Tuberculosis (TB) remains a leading infectious cause of death globally, disproportionately affecting low-income populations.
• TB-associated lung diseases (TBALD) can occur before, during, or after TB treatment, leading to persistent respiratory impairment.
• Post-TB lung disease (PTLD) significantly impacts quality of life, social activities, and long-term survival.

Purpose of the Study:

• To highlight the burden and consequences of TBALD and PTLD.
• To identify risk factors associated with PTLD development.
• To outline strategies for PTLD prevention and management.

Main Methods:

• Literature review and synthesis of current evidence on TBALD and PTLD.
• Analysis of risk factors including age, smoking, HIV, diagnostic delays, and socioeconomic status.
• Examination of intervention points for PTLD mitigation across the TB care continuum.

Main Results:

• PTLD is characterized by persistent respiratory symptoms and lung impairment post-TB treatment.
• Key risk factors for PTLD include older age, smoking, HIV, delayed diagnosis, and poor socioeconomic conditions.
• Interventions before, during, and after TB treatment can limit PTLD's impact.

Conclusions:

• Early detection, clinical assessment, and tailored management are vital for mitigating PTLD-related disability.
• Healthcare providers and national programs are essential for patient follow-up, education, and integrated care.
• Sustained funding and research are critical for advancing PTLD care and developing new tools.